We do not maintain any pre-compounded stock of this product
Fatigue in the first couple weeks is normal as your caloric intake drops and your body adapts
Abstract Treatment with glucagon-like peptide-1 receptor agonists (GLP1-RA) in patients with type 2 diabetes (T2D) and chronic kidney disease (CKD) may attenuate kidney disease progression and cardiovascular events but their real-world impact on healthcare utilization and mortality in this population are not well-defined
Exceeding the recommended C rating can lead to overheating, diminished performance, and, in severe cases, thermal runaway or fire
If you start a GLP-1 and your fatigue suddenly worsens, you will have the data to show your GP, helping them determine if it is a side effect of the new drug or a sign that your thyroid needs adjusting
consider electrolyte support if clinically appropriate